1st March 2013
Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")
Top Ten Equity Holdings - 28 February 2013
Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 28 February 2013 the top ten equity holdings and the sector breakdown were as follows:
Top 10 Longs |
% |
Pfizer |
8.5% |
Novartis |
7.9% |
Merck & Co |
6.7% |
GlaxoSmithKline |
6.4% |
Roche Holding |
5.8% |
Sanofi |
4.8% |
Astellas Pharma |
4.3% |
Eli Lilly |
3.8% |
Takeda Pharmaceutical Company NPV |
3.6% |
Bristol Myers Squibb |
3.6% |
Total |
55.4% |
Sector Exposure |
Total % |
Pharmaceuticals |
68.0% |
Health Care Equipment |
7.3% |
Specialized REITs |
7.1% |
Health Care Facilities |
5.0% |
Health Care Services |
3.3% |
Biotechnology |
3.0% |
Health Care Supplies |
1.8% |
Health Care Distributors |
1.3% |
Health Care Technology |
1.2% |
Life Sciences Tools & Services |
0.8% |
Life & Health Insurance |
0.5% |
Multi-line Insurance |
0.1% |
Cash |
0.6% |
Total |
100.0% |
A copy of the entire portfolio is available to view on the Company's website.
The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.com
Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.